The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Adenosine signaling is implicated in ethanol intoxication.
• Ethanol inhibits equilibrative nucleoside transporter 1 (ENT1) in vitro.
• Chronic ethanol exposure downregulates ENT1.

Purpose of the Study:

• To investigate the in vivo role of ENT1 in ethanol intoxication and consumption.
• To elucidate the relationship between ENT1, adenosine signaling, and alcohol-related behaviors.

Main Methods:

• Utilized ENT1-null mice and wild-type littermates.
• Assessed behavioral responses (hypnosis, ataxia) to ethanol.
• Measured alcohol consumption.
• Electrophysiological recordings in the nucleus accumbens to assess A(1) receptor function.
• Measured CRE-binding protein (CREB) phosphorylation in the striatum.
• Administered A(1) receptor agonist to ENT1-null mice.

Main Results:

• ENT1-null mice exhibited reduced hypnotic and ataxic effects of ethanol.
• ENT1-null mice consumed significantly more alcohol compared to wild-type.
• Reduced adenosine tone and impaired A(1) receptor-mediated inhibition of glutamate EPSCs were observed in ENT1-null mice.
• Increased CREB phosphorylation in the striatum of ENT1-null mice.
• A(1) receptor agonist treatment reduced EPSC amplitude and alcohol consumption in ENT1-null mice.

Conclusions:

• ENT1 plays a significant physiological role in mediating ethanol-induced behaviors.
• Decreased A(1) adenosine receptor function is linked to increased alcohol consumption.
• Targeting ENT1 or adenosine signaling may offer therapeutic strategies for alcohol use disorders.